Industry Research Reports

Home > Reports > Service & Software > Gene Knockdown Stable Cell Line Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Gene Knockdown Stable Cell Line Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Service & Software

Published Date: 2024-12-04

Pages: 104 Pages

Report ld: 3391574

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Gene Knockdown Stable Cell Line Service Market Size(US$)

CAGR 2024-2030

5.2%

Market Size,2030

USD 329

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 243 million

Market Forecast in 2030(Value)

US$ 329 million

CAGR

5.2%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Gene Knockdown Stable Cell Line Service was estimated to be worth US$ 218 million in 2023 and is forecast to a readjusted size of US$ 329 million by 2030 with a CAGR of 5.2% during the forecast period 2024-2030.

Gene Knockdown Stable Cell Line Service is a professional biomedical research service that aims to permanently knock out specific genes in cells through specific technical means, and this knockdown state can be stably maintained during multiple cell generations.

North American market for Gene Knockdown Stable Cell Line Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Gene Knockdown Stable Cell Line Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Gene Knockdown Stable Cell Line Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Gene Knockdown Stable Cell Line Service include AMSBIO, Aptagen, Aptamer Group, PORTON, Base Pair, Base Pair Biotechnologies, Cambio, CD Bioparticles, Creative Biolabs, Eurogentec, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

The Gene Knockdown Stable Cell Line Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Knockdown Stable Cell Line Service.

MARKET SEGMENTATION

By Company

AMSBIO
Aptagen
Aptamer Group
PORTON
Base Pair
Base Pair Biotechnologies
Cambio
CD Bioparticles
Creative Biolabs
Eurogentec
Novaptech

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

RNA Interference
CRISPRs
Others

Segment by Application

Genomics
Design Disease Models
Biopharmaceutical Research
Drug Discovery
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Gene Knockdown Stable Cell Line Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Gene Knockdown Stable Cell Line Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Gene Knockdown Stable Cell Line Service in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Gene Knockdown Stable Cell Line Service Product Introduction

1.2 Global Gene Knockdown Stable Cell Line Service Market Size Forecast (2019-2030)

1.3 Gene Knockdown Stable Cell Line Service Market Trends & Drivers

1.3.1 Gene Knockdown Stable Cell Line Service Industry Trends

1.3.2 Gene Knockdown Stable Cell Line Service Market Drivers & Opportunity

1.3.3 Gene Knockdown Stable Cell Line Service Market Challenges

1.3.4 Gene Knockdown Stable Cell Line Service Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Gene Knockdown Stable Cell Line Service Players Revenue Ranking (2023)

2.2 Global Gene Knockdown Stable Cell Line Service Revenue by Company (2019-2024)

2.3 Key Companies Gene Knockdown Stable Cell Line Service Manufacturing Base Distribution and Headquarters

2.4 Key Companies Gene Knockdown Stable Cell Line Service Product Offered

2.5 Key Companies Time to Begin Mass Production of Gene Knockdown Stable Cell Line Service

2.6 Gene Knockdown Stable Cell Line Service Market Competitive Analysis

2.6.1 Gene Knockdown Stable Cell Line Service Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Gene Knockdown Stable Cell Line Service Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Knockdown Stable Cell Line Service as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 RNA Interference

3.1.2 CRISPRs

3.1.3 Others

3.2 Global Gene Knockdown Stable Cell Line Service Sales Value by Type

3.2.1 Global Gene Knockdown Stable Cell Line Service Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Gene Knockdown Stable Cell Line Service Sales Value, by Type (2019-2030)

3.2.3 Global Gene Knockdown Stable Cell Line Service Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Genomics

4.1.2 Design Disease Models

4.1.3 Biopharmaceutical Research

4.1.4 Drug Discovery

4.1.5 Others

4.2 Global Gene Knockdown Stable Cell Line Service Sales Value by Application

4.2.1 Global Gene Knockdown Stable Cell Line Service Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Gene Knockdown Stable Cell Line Service Sales Value, by Application (2019-2030)

4.2.3 Global Gene Knockdown Stable Cell Line Service Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Gene Knockdown Stable Cell Line Service Sales Value by Region

5.1.1 Global Gene Knockdown Stable Cell Line Service Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Gene Knockdown Stable Cell Line Service Sales Value by Region (2019-2024)

5.1.3 Global Gene Knockdown Stable Cell Line Service Sales Value by Region (2025-2030)

5.1.4 Global Gene Knockdown Stable Cell Line Service Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Gene Knockdown Stable Cell Line Service Sales Value, 2019-2030

5.2.2 North America Gene Knockdown Stable Cell Line Service Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Gene Knockdown Stable Cell Line Service Sales Value, 2019-2030

5.3.2 Europe Gene Knockdown Stable Cell Line Service Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Gene Knockdown Stable Cell Line Service Sales Value, 2019-2030

5.4.2 Asia Pacific Gene Knockdown Stable Cell Line Service Sales Value by Region (%), 2023 VS 2030

5.5 South America

5.5.1 South America Gene Knockdown Stable Cell Line Service Sales Value, 2019-2030

5.5.2 South America Gene Knockdown Stable Cell Line Service Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Gene Knockdown Stable Cell Line Service Sales Value, 2019-2030

5.6.2 Middle East & Africa Gene Knockdown Stable Cell Line Service Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Gene Knockdown Stable Cell Line Service Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Gene Knockdown Stable Cell Line Service Sales Value, 2019-2030

6.3 United States

6.3.1 United States Gene Knockdown Stable Cell Line Service Sales Value, 2019-2030

6.3.2 United States Gene Knockdown Stable Cell Line Service Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Gene Knockdown Stable Cell Line Service Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Gene Knockdown Stable Cell Line Service Sales Value, 2019-2030

6.4.2 Europe Gene Knockdown Stable Cell Line Service Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Gene Knockdown Stable Cell Line Service Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Gene Knockdown Stable Cell Line Service Sales Value, 2019-2030

6.5.2 China Gene Knockdown Stable Cell Line Service Sales Value by Type (%), 2023 VS 2030

6.5.3 China Gene Knockdown Stable Cell Line Service Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Gene Knockdown Stable Cell Line Service Sales Value, 2019-2030

6.6.2 Japan Gene Knockdown Stable Cell Line Service Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Gene Knockdown Stable Cell Line Service Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Gene Knockdown Stable Cell Line Service Sales Value, 2019-2030

6.7.2 South Korea Gene Knockdown Stable Cell Line Service Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Gene Knockdown Stable Cell Line Service Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Gene Knockdown Stable Cell Line Service Sales Value, 2019-2030

6.8.2 Southeast Asia Gene Knockdown Stable Cell Line Service Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Gene Knockdown Stable Cell Line Service Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Gene Knockdown Stable Cell Line Service Sales Value, 2019-2030

6.9.2 India Gene Knockdown Stable Cell Line Service Sales Value by Type (%), 2023 VS 2030

6.9.3 India Gene Knockdown Stable Cell Line Service Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 AMSBIO

7.1.1 AMSBIO Profile

7.1.2 AMSBIO Main Business

7.1.3 AMSBIO Gene Knockdown Stable Cell Line Service Products, Services and Solutions

7.1.4 AMSBIO Gene Knockdown Stable Cell Line Service Revenue (US$ Million) & (2019-2024)

7.1.5 AMSBIO Recent Developments

7.2 Aptagen

7.2.1 Aptagen Profile

7.2.2 Aptagen Main Business

7.2.3 Aptagen Gene Knockdown Stable Cell Line Service Products, Services and Solutions

7.2.4 Aptagen Gene Knockdown Stable Cell Line Service Revenue (US$ Million) & (2019-2024)

7.2.5 Aptagen Recent Developments

7.3 Aptamer Group

7.3.1 Aptamer Group Profile

7.3.2 Aptamer Group Main Business

7.3.3 Aptamer Group Gene Knockdown Stable Cell Line Service Products, Services and Solutions

7.3.4 Aptamer Group Gene Knockdown Stable Cell Line Service Revenue (US$ Million) & (2019-2024)

7.3.5 Aptamer Group Recent Developments

7.4 PORTON

7.4.1 PORTON Profile

7.4.2 PORTON Main Business

7.4.3 PORTON Gene Knockdown Stable Cell Line Service Products, Services and Solutions

7.4.4 PORTON Gene Knockdown Stable Cell Line Service Revenue (US$ Million) & (2019-2024)

7.4.5 PORTON Recent Developments

7.5 Base Pair

7.5.1 Base Pair Profile

7.5.2 Base Pair Main Business

7.5.3 Base Pair Gene Knockdown Stable Cell Line Service Products, Services and Solutions

7.5.4 Base Pair Gene Knockdown Stable Cell Line Service Revenue (US$ Million) & (2019-2024)

7.5.5 Base Pair Recent Developments

7.6 Base Pair Biotechnologies

7.6.1 Base Pair Biotechnologies Profile

7.6.2 Base Pair Biotechnologies Main Business

7.6.3 Base Pair Biotechnologies Gene Knockdown Stable Cell Line Service Products, Services and Solutions

7.6.4 Base Pair Biotechnologies Gene Knockdown Stable Cell Line Service Revenue (US$ Million) & (2019-2024)

7.6.5 Base Pair Biotechnologies Recent Developments

7.7 Cambio

7.7.1 Cambio Profile

7.7.2 Cambio Main Business

7.7.3 Cambio Gene Knockdown Stable Cell Line Service Products, Services and Solutions

7.7.4 Cambio Gene Knockdown Stable Cell Line Service Revenue (US$ Million) & (2019-2024)

7.7.5 Cambio Recent Developments

7.8 CD Bioparticles

7.8.1 CD Bioparticles Profile

7.8.2 CD Bioparticles Main Business

7.8.3 CD Bioparticles Gene Knockdown Stable Cell Line Service Products, Services and Solutions

7.8.4 CD Bioparticles Gene Knockdown Stable Cell Line Service Revenue (US$ Million) & (2019-2024)

7.8.5 CD Bioparticles Recent Developments

7.9 Creative Biolabs

7.9.1 Creative Biolabs Profile

7.9.2 Creative Biolabs Main Business

7.9.3 Creative Biolabs Gene Knockdown Stable Cell Line Service Products, Services and Solutions

7.9.4 Creative Biolabs Gene Knockdown Stable Cell Line Service Revenue (US$ Million) & (2019-2024)

7.9.5 Creative Biolabs Recent Developments

7.10 Eurogentec

7.10.1 Eurogentec Profile

7.10.2 Eurogentec Main Business

7.10.3 Eurogentec Gene Knockdown Stable Cell Line Service Products, Services and Solutions

7.10.4 Eurogentec Gene Knockdown Stable Cell Line Service Revenue (US$ Million) & (2019-2024)

7.10.5 Eurogentec Recent Developments

7.11 Novaptech

7.11.1 Novaptech Profile

7.11.2 Novaptech Main Business

7.11.3 Novaptech Gene Knockdown Stable Cell Line Service Products, Services and Solutions

7.11.4 Novaptech Gene Knockdown Stable Cell Line Service Revenue (US$ Million) & (2019-2024)

7.11.5 Novaptech Recent Developments

8 Industry Chain Analysis

8.1 Gene Knockdown Stable Cell Line Service Industrial Chain

8.2 Gene Knockdown Stable Cell Line Service Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Gene Knockdown Stable Cell Line Service Sales Model

8.5.2 Sales Channel

8.5.3 Gene Knockdown Stable Cell Line Service Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Gene Knockdown Stable Cell Line Service Market Trends

Table 2. Gene Knockdown Stable Cell Line Service Market Drivers & Opportunity

Table 3. Gene Knockdown Stable Cell Line Service Market Challenges

Table 4. Gene Knockdown Stable Cell Line Service Market Restraints

Table 5. Global Gene Knockdown Stable Cell Line Service Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Gene Knockdown Stable Cell Line Service Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Gene Knockdown Stable Cell Line Service Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Gene Knockdown Stable Cell Line Service Product Type

Table 9. Key Companies Time to Begin Mass Production of Gene Knockdown Stable Cell Line Service

Table 10. Global Gene Knockdown Stable Cell Line Service Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Knockdown Stable Cell Line Service as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Gene Knockdown Stable Cell Line Service Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Gene Knockdown Stable Cell Line Service Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Gene Knockdown Stable Cell Line Service Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Gene Knockdown Stable Cell Line Service Sales Market Share in Value by Type (2019-2024)

Table 17. Global Gene Knockdown Stable Cell Line Service Sales Market Share in Value by Type (2025-2030)

Table 18. Global Gene Knockdown Stable Cell Line Service Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Gene Knockdown Stable Cell Line Service Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Gene Knockdown Stable Cell Line Service Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Gene Knockdown Stable Cell Line Service Sales Market Share in Value by Application (2019-2024)

Table 22. Global Gene Knockdown Stable Cell Line Service Sales Market Share in Value by Application (2025-2030)

Table 23. Global Gene Knockdown Stable Cell Line Service Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)

Table 24. Global Gene Knockdown Stable Cell Line Service Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Gene Knockdown Stable Cell Line Service Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Gene Knockdown Stable Cell Line Service Sales Value by Region (2019-2024) & (%)

Table 27. Global Gene Knockdown Stable Cell Line Service Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Gene Knockdown Stable Cell Line Service Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Gene Knockdown Stable Cell Line Service Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Gene Knockdown Stable Cell Line Service Sales Value, (2025-2030) & (US$ Million)

Table 31. AMSBIO Basic Information List

Table 32. AMSBIO Description and Business Overview

Table 33. AMSBIO Gene Knockdown Stable Cell Line Service Products, Services and Solutions

Table 34. Revenue (US$ Million) in Gene Knockdown Stable Cell Line Service Business of AMSBIO (2019-2024)

Table 35. AMSBIO Recent Developments

Table 36. Aptagen Basic Information List

Table 37. Aptagen Description and Business Overview

Table 38. Aptagen Gene Knockdown Stable Cell Line Service Products, Services and Solutions

Table 39. Revenue (US$ Million) in Gene Knockdown Stable Cell Line Service Business of Aptagen (2019-2024)

Table 40. Aptagen Recent Developments

Table 41. Aptamer Group Basic Information List

Table 42. Aptamer Group Description and Business Overview

Table 43. Aptamer Group Gene Knockdown Stable Cell Line Service Products, Services and Solutions

Table 44. Revenue (US$ Million) in Gene Knockdown Stable Cell Line Service Business of Aptamer Group (2019-2024)

Table 45. Aptamer Group Recent Developments

Table 46. PORTON Basic Information List

Table 47. PORTON Description and Business Overview

Table 48. PORTON Gene Knockdown Stable Cell Line Service Products, Services and Solutions

Table 49. Revenue (US$ Million) in Gene Knockdown Stable Cell Line Service Business of PORTON (2019-2024)

Table 50. PORTON Recent Developments

Table 51. Base Pair Basic Information List

Table 52. Base Pair Description and Business Overview

Table 53. Base Pair Gene Knockdown Stable Cell Line Service Products, Services and Solutions

Table 54. Revenue (US$ Million) in Gene Knockdown Stable Cell Line Service Business of Base Pair (2019-2024)

Table 55. Base Pair Recent Developments

Table 56. Base Pair Biotechnologies Basic Information List

Table 57. Base Pair Biotechnologies Description and Business Overview

Table 58. Base Pair Biotechnologies Gene Knockdown Stable Cell Line Service Products, Services and Solutions

Table 59. Revenue (US$ Million) in Gene Knockdown Stable Cell Line Service Business of Base Pair Biotechnologies (2019-2024)

Table 60. Base Pair Biotechnologies Recent Developments

Table 61. Cambio Basic Information List

Table 62. Cambio Description and Business Overview

Table 63. Cambio Gene Knockdown Stable Cell Line Service Products, Services and Solutions

Table 64. Revenue (US$ Million) in Gene Knockdown Stable Cell Line Service Business of Cambio (2019-2024)

Table 65. Cambio Recent Developments

Table 66. CD Bioparticles Basic Information List

Table 67. CD Bioparticles Description and Business Overview

Table 68. CD Bioparticles Gene Knockdown Stable Cell Line Service Products, Services and Solutions

Table 69. Revenue (US$ Million) in Gene Knockdown Stable Cell Line Service Business of CD Bioparticles (2019-2024)

Table 70. CD Bioparticles Recent Developments

Table 71. Creative Biolabs Basic Information List

Table 72. Creative Biolabs Description and Business Overview

Table 73. Creative Biolabs Gene Knockdown Stable Cell Line Service Products, Services and Solutions

Table 74. Revenue (US$ Million) in Gene Knockdown Stable Cell Line Service Business of Creative Biolabs (2019-2024)

Table 75. Creative Biolabs Recent Developments

Table 76. Eurogentec Basic Information List

Table 77. Eurogentec Description and Business Overview

Table 78. Eurogentec Gene Knockdown Stable Cell Line Service Products, Services and Solutions

Table 79. Revenue (US$ Million) in Gene Knockdown Stable Cell Line Service Business of Eurogentec (2019-2024)

Table 80. Eurogentec Recent Developments

Table 81. Novaptech Basic Information List

Table 82. Novaptech Description and Business Overview

Table 83. Novaptech Gene Knockdown Stable Cell Line Service Products, Services and Solutions

Table 84. Revenue (US$ Million) in Gene Knockdown Stable Cell Line Service Business of Novaptech (2019-2024)

Table 85. Novaptech Recent Developments

Table 86. Key Raw Materials Lists

Table 87. Raw Materials Key Suppliers Lists

Table 88. Gene Knockdown Stable Cell Line Service Downstream Customers

Table 89. Gene Knockdown Stable Cell Line Service Distributors List

Table 90. Research Programs/Design for This Report

Table 91. Key Data Information from Secondary Sources

Table 92. Key Data Information from Primary Sources

Table 93. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Gene Knockdown Stable Cell Line Service Product Picture

Figure 2. Global Gene Knockdown Stable Cell Line Service Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Gene Knockdown Stable Cell Line Service Sales Value (2019-2030) & (US$ Million)

Figure 4. Gene Knockdown Stable Cell Line Service Report Years Considered

Figure 5. Global Gene Knockdown Stable Cell Line Service Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Gene Knockdown Stable Cell Line Service Revenue in 2023

Figure 7. Gene Knockdown Stable Cell Line Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. RNA Interference Picture

Figure 9. CRISPRs Picture

Figure 10. Others Picture

Figure 11. Global Gene Knockdown Stable Cell Line Service Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Gene Knockdown Stable Cell Line Service Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Genomics

Figure 14. Product Picture of Design Disease Models

Figure 15. Product Picture of Biopharmaceutical Research

Figure 16. Product Picture of Drug Discovery

Figure 17. Product Picture of Others

Figure 18. Global Gene Knockdown Stable Cell Line Service Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global Gene Knockdown Stable Cell Line Service Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America Gene Knockdown Stable Cell Line Service Sales Value (2019-2030) & (US$ Million)

Figure 21. North America Gene Knockdown Stable Cell Line Service Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe Gene Knockdown Stable Cell Line Service Sales Value, (2019-2030) & (US$ Million)

Figure 23. Europe Gene Knockdown Stable Cell Line Service Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific Gene Knockdown Stable Cell Line Service Sales Value, (2019-2030) & (US$ Million)

Figure 25. Asia Pacific Gene Knockdown Stable Cell Line Service Sales Value by Region (%), 2023 VS 2030

Figure 26. South America Gene Knockdown Stable Cell Line Service Sales Value, (2019-2030) & (US$ Million)

Figure 27. South America Gene Knockdown Stable Cell Line Service Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa Gene Knockdown Stable Cell Line Service Sales Value, (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa Gene Knockdown Stable Cell Line Service Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions Gene Knockdown Stable Cell Line Service Sales Value (%), (2019-2030)

Figure 31. United States Gene Knockdown Stable Cell Line Service Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States Gene Knockdown Stable Cell Line Service Sales Value by Type (%), 2023 VS 2030

Figure 33. United States Gene Knockdown Stable Cell Line Service Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe Gene Knockdown Stable Cell Line Service Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe Gene Knockdown Stable Cell Line Service Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe Gene Knockdown Stable Cell Line Service Sales Value by Application (%), 2023 VS 2030

Figure 37. China Gene Knockdown Stable Cell Line Service Sales Value, (2019-2030) & (US$ Million)

Figure 38. China Gene Knockdown Stable Cell Line Service Sales Value by Type (%), 2023 VS 2030

Figure 39. China Gene Knockdown Stable Cell Line Service Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan Gene Knockdown Stable Cell Line Service Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan Gene Knockdown Stable Cell Line Service Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan Gene Knockdown Stable Cell Line Service Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea Gene Knockdown Stable Cell Line Service Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea Gene Knockdown Stable Cell Line Service Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea Gene Knockdown Stable Cell Line Service Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia Gene Knockdown Stable Cell Line Service Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Gene Knockdown Stable Cell Line Service Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia Gene Knockdown Stable Cell Line Service Sales Value by Application (%), 2023 VS 2030

Figure 49. India Gene Knockdown Stable Cell Line Service Sales Value, (2019-2030) & (US$ Million)

Figure 50. India Gene Knockdown Stable Cell Line Service Sales Value by Type (%), 2023 VS 2030

Figure 51. India Gene Knockdown Stable Cell Line Service Sales Value by Application (%), 2023 VS 2030

Figure 52. Gene Knockdown Stable Cell Line Service Industrial Chain

Figure 53. Gene Knockdown Stable Cell Line Service Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Gene Knockdown Stable Cell Line Service in 2024? zhanKai

The global market size of Gene Knockdown Stable Cell Line Service in 2024 was 243 Million USD.

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Gene Knockdown Stable Cell Line Service market? shouQi

What is the annual compound growth rate of the global Gene Knockdown Stable Cell Line Service market size from 2024 to 2030? shouQi

What was the global market size of Gene Knockdown Stable Cell Line Service in 2030? shouQi

Related Reports

Global Gene Knockdown Stable Cell Line Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Gene Knockdown Stable Cell Line Service market is projected to grow from US$ 254 million in 2025 to US$ 361 million by 2032, at a CAGR of 5.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-25
Pages: 131
USD 4900.00
(Single User License)
Global Gene Knockdown Stable Cell Line Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Gene Knockdown Stable Cell Line Service market size was US$ 254 million in 2025 and is forecast to reach a readjusted size of US$ 361 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 92
USD 4250.00
(Single User License)
Global Gene Knockdown Stable Cell Line Service Market Research Report 2026
The global Gene Knockdown Stable Cell Line Service market was valued at US$ 254 million in 2025 and is anticipated to reach US$ 361 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 111
USD 2900.00
(Single User License)
Gene Knockdown Stable Cell Line Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gene Knockdown Stable Cell Line Service was estimated to be worth US$ 254 million in 2025 and is projected to reach US$ 361 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 101
USD 3950.00
(Single User License)
Global Gene Knockdown Stable Cell Line Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Gene Knockdown Stable Cell Line Service market size was US$ 243 million in 2024 and is forecast to a readjusted size of US$ 345 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 95
USD 4250.00
(Single User License)
Global Gene Knockdown Stable Cell Line Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Gene Knockdown Stable Cell Line Service market is projected to grow from US$ 243 million in 2024 to US$ 345 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-01
Pages: 134
USD 4900.00
(Single User License)
Gene Knockdown Stable Cell Line Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gene Knockdown Stable Cell Line Service was estimated to be worth US$ 243 million in 2024 and is forecast to a readjusted size of US$ 345 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 112
USD 3950.00
(Single User License)
Global Gene Knockdown Stable Cell Line Service Market Research Report 2025
The global market for Gene Knockdown Stable Cell Line Service was valued at US$ 243 million in the year 2024 and is projected to reach a revised size of US$ 345 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-03-12
Pages: 84
USD 2900.00
(Single User License)
Global Gene Knockdown Stable Cell Line Service Market Insights, Forecast to 2030
Valued at US$ 243 million in 2024, the global Gene Knockdown Stable Cell Line Service market is forecast to reach US$ 329 million by 2030, at a CAGR of 5.2% during the forecast period.
Published Date: 2024-12-04
Pages: 139
USD 4900.00
(Single User License)
Global and United States Gene Knockdown Stable Cell Line Service Market Report & Forecast 2024-2030
The global Gene Knockdown Stable Cell Line Service revenue was US$ 218 million in 2023 and is forecast to a readjusted size of US$ 329 million by 2030 with a CAGR of 5.2% during the review period (2024-2030).
Published Date: 2024-12-04
Pages: 120
USD 4350.00
(Single User License)

Global Gene Knockdown Stable Cell Line Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Gene Knockdown Stable Cell Line Service market is projected to grow from US$ 254 million in 2025 to US$ 361 million by 2032, at a CAGR of 5.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-25
Pages: 131
USD 4900.00 (Single User License)
Global Gene Knockdown Stable Cell Line Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Gene Knockdown Stable Cell Line Service market size was US$ 254 million in 2025 and is forecast to reach a readjusted size of US$ 361 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 92
USD 4250.00 (Single User License)
Global Gene Knockdown Stable Cell Line Service Market Research Report 2026
The global Gene Knockdown Stable Cell Line Service market was valued at US$ 254 million in 2025 and is anticipated to reach US$ 361 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 111
USD 2900.00 (Single User License)
Gene Knockdown Stable Cell Line Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gene Knockdown Stable Cell Line Service was estimated to be worth US$ 254 million in 2025 and is projected to reach US$ 361 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 101
USD 3950.00 (Single User License)
Global Gene Knockdown Stable Cell Line Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Gene Knockdown Stable Cell Line Service market size was US$ 243 million in 2024 and is forecast to a readjusted size of US$ 345 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 95
USD 4250.00 (Single User License)
Global Gene Knockdown Stable Cell Line Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Gene Knockdown Stable Cell Line Service market is projected to grow from US$ 243 million in 2024 to US$ 345 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-01
Pages: 134
USD 4900.00 (Single User License)
Gene Knockdown Stable Cell Line Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gene Knockdown Stable Cell Line Service was estimated to be worth US$ 243 million in 2024 and is forecast to a readjusted size of US$ 345 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 112
USD 3950.00 (Single User License)
Global Gene Knockdown Stable Cell Line Service Market Research Report 2025
The global market for Gene Knockdown Stable Cell Line Service was valued at US$ 243 million in the year 2024 and is projected to reach a revised size of US$ 345 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-03-12
Pages: 84
USD 2900.00 (Single User License)
Global Gene Knockdown Stable Cell Line Service Market Insights, Forecast to 2030
Valued at US$ 243 million in 2024, the global Gene Knockdown Stable Cell Line Service market is forecast to reach US$ 329 million by 2030, at a CAGR of 5.2% during the forecast period.
Published: 2024-12-04
Pages: 139
USD 4900.00 (Single User License)
Global and United States Gene Knockdown Stable Cell Line Service Market Report & Forecast 2024-2030
The global Gene Knockdown Stable Cell Line Service revenue was US$ 218 million in 2023 and is forecast to a readjusted size of US$ 329 million by 2030 with a CAGR of 5.2% during the review period (2024-2030).
Published: 2024-12-04
Pages: 120
USD 4350.00 (Single User License)